Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver.
Open Access
- 1 May 1982
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 13 (5) , 637-645
- https://doi.org/10.1111/j.1365-2125.1982.tb01430.x
Abstract
1 A method for the assay of debrisoquine 4‐hydroxylase activity in vitro by microsomal fractions of human liver is described. The assay utilises gas chromatography‐mass spectrometry with d9‐4‐ hydroxydebrisoquine as internal standard. 2 The limit of detection of 4‐ hydroxydebrisoquine was 2 ng ml −1 and the coefficient of variation was 4.4%. 3 Debrisoquine 4‐hydroxylase activity was linear with protein to concentrations above 2.1 mg ml −1 and with incubation times of at least 15 min. 4 Debrisoquine 4‐hydroxylase is a microsomal enzyme with a requirement for NADPH. Activity was inhibited by carbon monoxide. It is concluded that the activity is catalysed by cytochrome P‐450. 5 In three samples of human liver the mean value for Vmax of debrisoquine 4‐ hydroxylase activity was 69.9 +/‐ 14.3 pmol mg −1 min −1 and for Km it was 130 +/‐ 24 microM. 6 The only variable from smoking status, alcohol ingestion, sex of the patients, source of liver sample and presence of liver disease that had a significant effect on 4‐hydroxylation of debrisoquine was the presence of liver disease. This was associated with a decrease in enzyme activity.Keywords
This publication has 27 references indexed in Scilit:
- GENETICALLY DETERMINED IMPAIRED DRUG SULPHOXIDATIONThe Lancet, 1981
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980
- GENETIC IMPAIRMENT OF PHENFORMIN METABOLISMThe Lancet, 1980
- Genetic evidence for the involvement of different oxidative mechanisms in drug oxidationJournal of Pharmacy and Pharmacology, 1979
- The metabolism of [14C]‐debrisoquine in man.British Journal of Clinical Pharmacology, 1979
- Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamineXenobiotica, 1979
- Polymorphism of carbon oxidation of drugs and clinical implications.BMJ, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1977
- Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometryAnalytical Chemistry, 1976
- Metabolism of Debrisoquine Sulphate in Rat, Dog and ManXenobiotica, 1976